Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 75397.74 938.21 (1.26%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
1	Laurus Labs Ltd.	Q V+ PT	1,29,243 Mid Cap	2,374.75 (-0.72%)	96.46	21.33	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Rubicon Research Ltd.	Q V+ PT	26,650 Small Cap	1,682 (4.48%)	92.47	19.85	41.00	54.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Acutaas Chemicals Ltd.	Q V+ PT	32,770 Small Cap	3,980.15 (-0.56%)	74.62	17.64	31.50	70.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Glaxosmithkline Pharmaceuticals Ltd.	Q V PT	42,073 Mid Cap	2,569 (3.44%)	39.39	16.69	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	CORONA Remedies Ltd.	Q V+ PT	13,125 Small Cap	2,194 (2.23%)	63.4	16.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Anthem Biosciences Ltd.	Q V PT	46,685 Mid Cap	826.60 (-0.22%)	81.06	14.92	14.00	16.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Vijaya Diagnostic Centre Ltd.	Q V+ PT	14,906 Small Cap	1,460.05 (0.88%)	79.51	14.8	16.66	14.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Divis Laboratories Ltd.	Q V+ PT	2,57,903 Large Cap	9,954.75 (2.47%)	88.17	14.6	8.67	4.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Aster DM Quality Care Ltd.	Q V+ PT	59,570 Mid Cap	687.70 (0.63%)	186.93	14.08	-11.61	19.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Thyrocare Technologies Ltd.	Q V PT	7,274 Small Cap	457.45 (0.10%)	50.44	13.14	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Suven Life Sciences Ltd.	Q V+ PT	7,293 Small Cap	262.40 (1.67%)	N/A	13.1	-12.01	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Sai Life Sciences Ltd.	Q V+ PT	33,139 Small Cap	1,564.60 (0.31%)	91.61	12.98	23.61	39.96	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Neuland Laboratories Ltd.	Q V+ PT	25,276 Small Cap	19,448.05 (-1.28%)	50.78	12.51	16.64	37.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Dr. Lal Pathlabs Ltd.	Q V PT	31,997 Small Cap	1,882.30 (-1.26%)	58.73	12.44	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,20,779 Large Cap	8,390 (-0.12%)	76.88	11.71	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Abbott India Ltd.	Q V PT	54,384 Mid Cap	25,801.50 (0.81%)	33.68	10.51	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Kwality Pharmaceuticals Ltd.	Q V+ PT	3,604 Small Cap	3,501.55 (0.81%)	44.47	10.11	13.94	34.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Wanbury Ltd.	Q V+ PT	664 Small Cap	189.85 (0.05%)	15.44	9.89	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,76,306 Large Cap	4,595 (-0.87%)	83.01	9.6	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Ajanta Pharma Ltd.	Q V+ PT	43,891 Mid Cap	3,429.75 (-2.35%)	34.76	9.03	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Global Health Ltd.	Q V PT	34,122 Small Cap	1,310 (3.23%)	61.35	8.3	24.97	76.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Dr. Agarwals Health Care Ltd.	Q V PT	16,117 Small Cap	512.45 (0.81%)	108.63	7.79	34.58	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Krishna Institute of Medical Sciences Ltd	Q V PT	29,480 Small Cap	712.10 (1.45%)	144.3	7.79	24.04	3.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Fredun Pharmaceuticals Ltd.	Q V+ PT	2,340 Small Cap	1,371.90 (0.43%)	53.39	7.67	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Max Healthcare Institute Ltd.	Q V PT	83,706 Mid Cap	897.10 (4.31%)	60.63	7.39	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Metropolis Healthcare Ltd.	Q V PT	11,310 Small Cap	548.70 (0.65%)	56.09	7.25	10.52	0.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Rainbow Childrens Medicare Ltd.	Q V PT	12,366 Small Cap	1,229 (0.94%)	42.32	7.21	21.24	43.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Narayana Hrudayalaya Ltd.	Q V PT	35,144 Small Cap	1,790 (4.09%)	40.92	7.02	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Shilpa Medicare Ltd.	Q V+ PT	18,671 Small Cap	940.25 (-1.51%)	62.8	6.95	11.30	12.66	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Emcure Pharmaceuticals Ltd.	Q V PT	35,440 Small Cap	1,869.50 (0.07%)	35.04	6.78	8.73	13.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Indegene	628.45	6.94%
Advanced Enzyme Tech	280.15	6.54%
One Global Service	461	5.46%
Evonile Pharma	1,778.15	4.98%
Rubicon Research	1,682	4.48%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Morepen Laboratories	108.05	-4.97%
Concord Biotech	1,187.70	-4.63%
Manipal Health Enter	640.05	-4.25%
Strides Pharma Scien	1,031.65	-3.51%
Sigachi Industries	25.50	-3.41%

News about Top Pharma Companies in India

Nov, 2026

RainbowChildrenS Med - Quaterly Results

A fair growth of 19.22% in the revenue at Rs. 4869.91 millions was reported in the September 2026 quarter as compared to Rs. 4084.96 millions during year-ago period.A meek growth of 2.63% was reported for the quarter ended September 2026 to Rs. 750.93 millions from Rs. 731.67 millions.Operating Profit saw a handsome growth to 1595.88 millions from 1488.91 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	4869.91	4084.96	19.22	8975.38	7432.44	20.76	15456.60	14545.06	6.27
Other Income	80.92	81.73	-0.99	208.49	274.58	-24.07	434.54	489.49	-11.23
PBIDT	1595.88	1488.91	7.18	2870.04	2676.97	7.21	5433.11	5234.23	3.80
Interest	199.14	173.09	15.05	391.63	347.02	12.86	713.96	695.94	2.59
PBDT	1396.74	1315.82	6.15	2478.41	2329.95	6.37	4703.76	4538.29	3.65
Depreciation	398.09	331.82	19.97	774.35	657.75	17.73	1362.61	1317.48	3.43
PBT	998.65	984.00	1.49	1704.06	1672.20	1.91	3341.15	3220.81	3.74
TAX	247.72	252.33	-1.83	426.07	423.33	0.65	840.99	844.98	-0.47
Deferred Tax	-57.47	-27.87	106.21	-68.71	-22.06	211.47	-73.38	-31.54	132.66
PAT	750.93	731.67	2.63	1277.99	1248.87	2.33	2500.16	2375.83	5.23
Equity	1015.66	1015.59	0.01	1015.66	1015.59	0.01	1015.59	1015.52	0.01
PBIDTM(%)	32.77	36.45	-10.09	31.98	36.02	-11.22	35.15	35.99	-2.32

Oct, 2026

Corona Remedies informs about newspaper publication

Corona Remedies has informed that the Board of Directors, at its meeting held on Friday, October 30, 2026 had considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the second quarter and half year ended on September 30, 2026. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, they are enclosed the newspaper advertisement of the Unaudited Financial Results, published today in Financial Express (English and Gujarati). The extract of aforesaid newspaper publication is also being made available on the website of the Company at www.coronaremedies.com

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Ajanta Pharma - Quaterly Results

The sales moved up 41.37% to Rs. 17250.70 millions for the September 2026 quarter as compared to Rs. 12202.40 millions during the year-ago period.Profit after tax for the quarter ended September 2026 reported a huge growth of 52.24% to Rs. 3798.90 millions from Rs. 2495.30 millions.Operating Profit saw a handsome growth to 5697.10 millions from 3646.20 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	17250.70	12202.40	41.37	32137.40	24288.00	32.32	48459.20	43220.40	12.12
Other Income	526.20	750.30	-29.87	1234.40	1156.60	6.73	2044.00	1198.70	70.52
PBIDT	5697.10	3646.20	56.25	10372.30	7346.50	41.19	14023.90	13245.90	5.87
Interest	7.90	7.30	8.22	15.50	14.60	6.16	25.90	46.00	-43.70
PBDT	5689.20	3638.90	56.34	10356.80	7331.90	41.26	13998.00	13199.90	6.05
Depreciation	463.00	419.20	10.45	896.10	822.30	8.97	1687.70	1399.30	20.61
PBT	5226.20	3219.70	62.32	9460.70	6509.60	45.33	12310.30	11800.60	4.32
TAX	1427.30	724.40	97.03	2507.10	1464.60	71.18	2842.10	2631.70	7.99
Deferred Tax	-158.10	64.70	-344.36	-94.60	97.60	-196.93	76.00	51.40	47.86
PAT	3798.90	2495.30	52.24	6953.60	5045.00	37.83	9468.20	9168.90	3.26
Equity	250.70	250.70	0.00	250.70	250.70	0.00	250.70	250.70	0.00
PBIDTM(%)	33.03	29.88	10.52	32.27	30.25	6.70	28.94	30.65	-5.57

Oct, 2026

Max Healthcare Inst. - Quaterly Results

The company witnessed a 14.30% growth in the revenue at Rs. 8419.70 millions for the quarter ended September 2026 as compared to Rs. 7366.20 millions during the year-ago period.Profit for the quarter ended September 2026 grew by 4.93% to Rs. 1683.30 millions from Rs. 1604.20 millions.Operating profit surged to 2786.40 millions from the corresponding previous quarter of 2611.00 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	8419.70	7366.20	14.30	16248.90	14306.40	13.58	28744.50	26636.00	7.92
Other Income	491.10	474.30	3.54	1412.10	1272.80	10.94	3019.50	3665.40	-17.62
PBIDT	2786.40	2611.00	6.72	5532.20	5286.60	4.65	11225.30	11999.30	-6.45
Interest	137.20	86.70	58.25	257.90	179.20	43.92	398.70	483.90	-17.61
PBDT	2649.20	2524.30	4.95	5274.30	5107.40	3.27	10670.20	10779.10	-1.01
Depreciation	387.70	367.70	5.44	753.70	722.00	4.39	1429.00	1311.90	8.93
PBT	2261.50	2156.60	4.86	4520.60	4385.40	3.08	9241.20	9467.20	-2.39
TAX	578.20	552.40	4.67	1161.30	1120.90	3.60	2075.10	2456.50	-15.53
Deferred Tax	-28.30	50.80	-155.71	-17.10	77.10	-122.18	196.70	482.90	-59.27
PAT	1683.30	1604.20	4.93	3359.30	3264.50	2.90	7166.10	7010.70	2.22
Equity	9733.10	9722.40	0.11	9733.10	9722.40	0.11	9731.30	9721.40	0.10
PBIDTM(%)	33.09	35.45	-6.64	34.05	36.95	-7.86	39.05	45.05	-13.31

Oct, 2026

Narayana Hrudayalay. - Quaterly Results

The revenue zoomed 16.31% to Rs. 11853.77 millions for the quarter ended September 2026 as compared to Rs. 10191.69 millions during the corresponding quarter last year.Good Net Profit growth of 27.38% reported above the corresponding previous quarter figure of Rs. 1378.80 millions to Rs. 1756.26 millioins.Operating profit for the quarter ended September 2026 rose to 3045.61 millions as compared to 2461.39 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	11853.77	10191.69	16.31	22824.79	19623.10	16.32	39751.41	35901.22	10.72
Other Income	433.50	170.88	153.69	737.63	335.24	120.03	1764.34	1421.63	24.11
PBIDT	3045.61	2461.39	23.74	5740.96	4415.93	30.01	10158.82	8137.02	24.85
Interest	352.30	285.78	23.28	688.96	592.01	16.38	1271.16	877.08	44.93
PBDT	2693.31	2175.61	23.80	5052.00	3823.92	32.12	8434.90	7259.94	16.18
Depreciation	501.09	462.66	8.31	982.57	938.24	4.72	1914.78	1692.63	13.12
PBT	2192.22	1712.95	27.98	4069.43	2885.68	41.02	6520.12	5567.31	17.11
TAX	435.96	334.15	30.47	934.62	633.17	47.61	1488.99	1255.89	18.56
Deferred Tax	17.03	18.36	-7.24	34.58	30.77	12.38	-75.93	187.21	-140.56
PAT	1756.26	1378.80	27.38	3134.81	2252.51	39.17	5031.13	4311.42	16.69
Equity	2043.61	2043.61	0.00	2043.61	2043.61	0.00	2043.61	2043.61	0.00
PBIDTM(%)	25.69	24.15	6.39	25.15	22.50	11.77	25.56	22.67	12.75

Oct, 2026

Max Healthcare Institute reports 16% fall in Q2 consolidated net profit

The total consolidated income of the company has increased by 20.37% at Rs 2,610.11 crore for Q2FY27

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Laurus Labs Ltd.	1,29,243 Crore
2	Rubicon Research Ltd.	26,650 Crore
3	Acutaas Chemicals Ltd.	32,770 Crore
4	Glaxosmithkline Pharmaceuticals Ltd.	42,073 Crore
5	CORONA Remedies Ltd.	13,125 Crore
6	Anthem Biosciences Ltd.	46,685 Crore
7	Vijaya Diagnostic Centre Ltd.	14,906 Crore
8	Divis Laboratories Ltd.	2,57,903 Crore
9	Aster DM Quality Care Ltd.	59,570 Crore
10	Thyrocare Technologies Ltd.	7,274 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,802	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,595	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,382	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,014	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,430	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,375	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,090	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,665	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,952	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,505	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,430	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,250	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,090	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,014	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,382	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,802	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,356	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

RainbowChildrenS Med - Quaterly Results

Corona Remedies informs about newspaper publication

Ajanta Pharma - Quaterly Results

Max Healthcare Inst. - Quaterly Results

Narayana Hrudayalay. - Quaterly Results

Max Healthcare Institute reports 16% fall in Q2 consolidated net profit

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?